Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
YSCH-01 by Shanghai Yuansong Biotechnology for Solid Tumor: Likelihood of Approval
YSCH-01 is under clinical development by Shanghai Yuansong Biotechnology and currently in Phase I for Solid Tumor. According to GlobalData,...